T. Bielik, M. Ňachajová, Š. Krivuš, P. Žúbor, J. Danko
Endometriosis is a hormone-dependent disease associated with dysmenorrhea,
dyspareunia, chronic pelvic pain and infertility, which significantly affects the quality
of life. The general prevalence of the disease is 5-10% of women in reproductive
age. The most frequent clinical manifestation is infertility, pelvic pain and pelvic tumors.
Endometriosis should be seen as a chronic disease requiring a long-term treatment
plan with maximum effort of use medication, with the aim to avoid repeated
surgical interventions. In the prevention of recurrence, it is effective shift from the
short-term intensive care (GnRHa) to long-term treatment, with minimal side-effects
and high compliance.